BELLRING BRANDS INC (BRBR)

US07831C1036 - Common Stock

76.1  -1.71 (-2.2%)

After market: 76.1 0 (0%)

Fundamental Rating

5

Taking everything into account, BRBR scores 5 out of 10 in our fundamental rating. BRBR was compared to 36 industry peers in the Personal Care Products industry. While BRBR has a great profitability rating, there are some minor concerns on its financial health. While showing a medium growth rate, BRBR is valued expensive at the moment.



7

1. Profitability

1.1 Basic Checks

BRBR had positive earnings in the past year.
BRBR had a positive operating cash flow in the past year.
Each year in the past 5 years BRBR has been profitable.
In the past 5 years BRBR always reported a positive cash flow from operatings.

1.2 Ratios

The Return On Assets of BRBR (29.45%) is better than 100.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 45.89%, BRBR belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BRBR is significantly above the industry average of 13.52%.
The last Return On Invested Capital (45.89%) for BRBR is above the 3 year average (38.65%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 29.45%
ROE N/A
ROIC 45.89%
ROA(3y)21.67%
ROA(5y)14.52%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)38.65%
ROIC(5y)33.76%

1.3 Margins

BRBR has a Profit Margin of 12.35%. This is amongst the best in the industry. BRBR outperforms 91.43% of its industry peers.
In the last couple of years the Profit Margin of BRBR has declined.
BRBR has a better Operating Margin (19.42%) than 91.43% of its industry peers.
In the last couple of years the Operating Margin of BRBR has remained more or less at the same level.
BRBR has a Gross Margin of 35.43%. This is in the lower half of the industry: BRBR underperforms 74.29% of its industry peers.
BRBR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.42%
PM (TTM) 12.35%
GM 35.43%
OM growth 3Y12.97%
OM growth 5Y0.42%
PM growth 3Y77.37%
PM growth 5Y-3.04%
GM growth 3Y4.59%
GM growth 5Y-0.59%

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BRBR is creating value.
Compared to 1 year ago, BRBR has less shares outstanding
The number of shares outstanding for BRBR has been increased compared to 5 years ago.
The debt/assets ratio for BRBR has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 10.20 indicates that BRBR is not in any danger for bankruptcy at the moment.
BRBR has a better Altman-Z score (10.20) than 88.57% of its industry peers.
BRBR has a debt to FCF ratio of 4.21. This is a neutral value as BRBR would need 4.21 years to pay back of all of its debts.
BRBR has a better Debt to FCF ratio (4.21) than 68.57% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4.21
Altman-Z 10.2
ROIC/WACC5.16
WACC8.9%

2.3 Liquidity

BRBR has a Current Ratio of 2.91. This indicates that BRBR is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of BRBR (2.91) is better than 77.14% of its industry peers.
A Quick Ratio of 1.51 indicates that BRBR should not have too much problems paying its short term obligations.
BRBR's Quick ratio of 1.51 is in line compared to the rest of the industry. BRBR outperforms 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.91
Quick Ratio 1.51

6

3. Growth

3.1 Past

BRBR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 46.21%, which is quite impressive.
BRBR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -12.29% yearly.
Looking at the last year, BRBR shows a quite strong growth in Revenue. The Revenue has grown by 19.76% in the last year.
Measured over the past years, BRBR shows a quite strong growth in Revenue. The Revenue has been growing by 18.50% on average per year.
EPS 1Y (TTM)46.21%
EPS 3Y27.55%
EPS 5Y-12.29%
EPS Q2Q%24.39%
Revenue 1Y (TTM)19.76%
Revenue growth 3Y16.98%
Revenue growth 5Y18.5%
Sales Q2Q%17.6%

3.2 Future

BRBR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.26% yearly.
The Revenue is expected to grow by 10.03% on average over the next years. This is quite good.
EPS Next Y15.18%
EPS Next 2Y15.29%
EPS Next 3Y15.68%
EPS Next 5Y14.26%
Revenue Next Year15.56%
Revenue Next 2Y13.22%
Revenue Next 3Y12.47%
Revenue Next 5Y10.03%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 39.43 indicates a quite expensive valuation of BRBR.
Compared to the rest of the industry, the Price/Earnings ratio of BRBR is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 27.73. BRBR is valued slightly more expensive when compared to this.
Based on the Price/Forward Earnings ratio of 34.23, the valuation of BRBR can be described as expensive.
BRBR's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of BRBR to the average of the S&P500 Index (22.83), we can say BRBR is valued slightly more expensively.
Industry RankSector Rank
PE 39.43
Fwd PE 34.23

4.2 Price Multiples

BRBR's Enterprise Value to EBITDA ratio is in line with the industry average.
BRBR's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 49.55
EV/EBITDA 24.9

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of BRBR may justify a higher PE ratio.
A more expensive valuation may be justified as BRBR's earnings are expected to grow with 15.68% in the coming years.
PEG (NY)2.6
PEG (5Y)N/A
EPS Next 2Y15.29%
EPS Next 3Y15.68%

0

5. Dividend

5.1 Amount

BRBR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BELLRING BRANDS INC

NYSE:BRBR (12/20/2024, 8:04:01 PM)

After market: 76.1 0 (0%)

76.1

-1.71 (-2.2%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)11-18 2024-11-18/amc
Earnings (Next)N/A N/A
Inst Owners97.95%
Inst Owner Change-1.06%
Ins Owners0.73%
Ins Owner Change1.78%
Market Cap9.80B
Analysts82.86
Price Target81.53 (7.14%)
Short Float %1.18%
Short Ratio1.57
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.75%
Min EPS beat(2)0.44%
Max EPS beat(2)19.07%
EPS beat(4)4
Avg EPS beat(4)14.89%
Min EPS beat(4)0.44%
Max EPS beat(4)31.81%
EPS beat(8)8
Avg EPS beat(8)12.37%
EPS beat(12)12
Avg EPS beat(12)13.45%
EPS beat(16)15
Avg EPS beat(16)13.69%
Revenue beat(2)1
Avg Revenue beat(2)0.67%
Min Revenue beat(2)-0.29%
Max Revenue beat(2)1.64%
Revenue beat(4)3
Avg Revenue beat(4)1.86%
Min Revenue beat(4)-0.29%
Max Revenue beat(4)3.78%
Revenue beat(8)6
Avg Revenue beat(8)1.85%
Revenue beat(12)7
Avg Revenue beat(12)0.12%
Revenue beat(16)10
Avg Revenue beat(16)1.02%
PT rev (1m)5.37%
PT rev (3m)23.92%
EPS NQ rev (1m)-0.45%
EPS NQ rev (3m)0.03%
EPS NY rev (1m)3.24%
EPS NY rev (3m)38.24%
Revenue NQ rev (1m)0.27%
Revenue NQ rev (3m)10.33%
Revenue NY rev (1m)4.14%
Revenue NY rev (3m)23.09%
Valuation
Industry RankSector Rank
PE 39.43
Fwd PE 34.23
P/S 4.91
P/FCF 49.55
P/OCF 49.1
P/B N/A
P/tB N/A
EV/EBITDA 24.9
EPS(TTM)1.93
EY2.54%
EPS(NY)2.22
Fwd EY2.92%
FCF(TTM)1.54
FCFY2.02%
OCF(TTM)1.55
OCFY2.04%
SpS15.5
BVpS-1.6
TBVpS-3.21
PEG (NY)2.6
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 29.45%
ROE N/A
ROCE 61.22%
ROIC 45.89%
ROICexc 51.69%
ROICexgc 81.98%
OM 19.42%
PM (TTM) 12.35%
GM 35.43%
FCFM 9.91%
ROA(3y)21.67%
ROA(5y)14.52%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)38.65%
ROIC(5y)33.76%
ROICexc(3y)42.57%
ROICexc(5y)39.59%
ROICexgc(3y)77.99%
ROICexgc(5y)768.49%
ROCE(3y)51.56%
ROCE(5y)45.04%
ROICexcg growth 3Y-71.38%
ROICexcg growth 5Y-2%
ROICexc growth 3Y6.3%
ROICexc growth 5Y16.08%
OM growth 3Y12.97%
OM growth 5Y0.42%
PM growth 3Y77.37%
PM growth 5Y-3.04%
GM growth 3Y4.59%
GM growth 5Y-0.59%
F-Score7
Asset Turnover2.38
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4.21
Debt/EBITDA 1.96
Cap/Depr 4.93%
Cap/Sales 0.09%
Interest Coverage 6.51
Cash Conversion 47.05%
Profit Quality 80.24%
Current Ratio 2.91
Quick Ratio 1.51
Altman-Z 10.2
F-Score7
WACC8.9%
ROIC/WACC5.16
Cap/Depr(3y)6.58%
Cap/Depr(5y)6.2%
Cap/Sales(3y)0.11%
Cap/Sales(5y)0.13%
Profit Quality(3y)77.59%
Profit Quality(5y)290.17%
High Growth Momentum
Growth
EPS 1Y (TTM)46.21%
EPS 3Y27.55%
EPS 5Y-12.29%
EPS Q2Q%24.39%
EPS Next Y15.18%
EPS Next 2Y15.29%
EPS Next 3Y15.68%
EPS Next 5Y14.26%
Revenue 1Y (TTM)19.76%
Revenue growth 3Y16.98%
Revenue growth 5Y18.5%
Sales Q2Q%17.6%
Revenue Next Year15.56%
Revenue Next 2Y13.22%
Revenue Next 3Y12.47%
Revenue Next 5Y10.03%
EBIT growth 1Y34.62%
EBIT growth 3Y32.15%
EBIT growth 5Y18.99%
EBIT Next Year21.53%
EBIT Next 3Y15.97%
EBIT Next 5Y12.8%
FCF growth 1Y-7.48%
FCF growth 3Y-4.13%
FCF growth 5Y15.77%
OCF growth 1Y-7.42%
OCF growth 3Y-4.07%
OCF growth 5Y15.22%